Skip to main content
Fig. 2 | Clinical and Translational Allergy

Fig. 2

From: Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study

Fig. 2

Site of icatibant-treated attacks by body mass index (BMI). P values comparing frequency of attacks between patients with normal/overweight/obese BMI: P = 0.020 for skin attacks; P = 0.003 for abdominal attacks; P = 0.282 for laryngeal attacks; P = 0.108 for attacks affecting other organs. Results excluding data from the two reinjection outliers are presented in Additional file 1: Figure S2. n = number of attacks

Back to article page